882 related articles for article (PubMed ID: 28486769)
1. Chemotherapy-induced peripheral neuropathy: A current review.
Staff NP; Grisold A; Grisold W; Windebank AJ
Ann Neurol; 2017 Jun; 81(6):772-781. PubMed ID: 28486769
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Marmiroli P
Curr Opin Neurol; 2015 Oct; 28(5):500-7. PubMed ID: 26197027
[TBL] [Abstract][Full Text] [Related]
3. Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study.
Gewandter JS; Chaudari J; Ibegbu C; Kitt R; Serventi J; Burke J; Culakova E; Kolb N; Sluka KA; Tejani MA; Mohile NA
Support Care Cancer; 2019 May; 27(5):1765-1774. PubMed ID: 30151681
[TBL] [Abstract][Full Text] [Related]
4. Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge.
Kandula T; Park SB; Cohn RJ; Krishnan AV; Farrar MA
Cancer Treat Rev; 2016 Nov; 50():118-128. PubMed ID: 27664395
[TBL] [Abstract][Full Text] [Related]
5. Individually tailored whole-body vibration training to reduce symptoms of chemotherapy-induced peripheral neuropathy: study protocol of a randomised controlled trial-VANISH.
Streckmann F; Hess V; Bloch W; Décard BF; Ritzmann R; Lehmann HC; Balke M; Koliamitra C; Oschwald V; Elter T; Zahner L; Donath L; Roth R; Faude O
BMJ Open; 2019 Apr; 9(4):e024467. PubMed ID: 31023750
[TBL] [Abstract][Full Text] [Related]
6. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.
Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V
Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261
[TBL] [Abstract][Full Text] [Related]
8. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
Knoerl R; Weller E; Halpenny B; Berry D
BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
[TBL] [Abstract][Full Text] [Related]
9. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update.
Loprinzi CL; Lacchetti C; Bleeker J; Cavaletti G; Chauhan C; Hertz DL; Kelley MR; Lavino A; Lustberg MB; Paice JA; Schneider BP; Lavoie Smith EM; Smith ML; Smith TJ; Wagner-Johnston N; Hershman DL
J Clin Oncol; 2020 Oct; 38(28):3325-3348. PubMed ID: 32663120
[TBL] [Abstract][Full Text] [Related]
10. Identifying trajectories and predictors of chemotherapy-induced peripheral neuropathy symptoms, physical functioning, and falls across treatment and recovery in adults treated with neurotoxic chemotherapy: the PATTERN observational study protocol (NCT05790538).
Winters-Stone KM; Krasnow SM; Horak FB; Mancini M; Cameron MH; Dieckmann NF; Stoyles SA; Roeland EJ
BMC Cancer; 2023 Nov; 23(1):1087. PubMed ID: 37946117
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy and peripheral neuropathy.
Li T; Mizrahi D; Goldstein D; Kiernan MC; Park SB
Neurol Sci; 2021 Oct; 42(10):4109-4121. PubMed ID: 34436727
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.
Gewandter JS; Kleckner AS; Marshall JH; Brown JS; Curtis LH; Bautista J; Dworkin RH; Kleckner IR; Kolb N; Mohile SG; Mustian KM
Support Care Cancer; 2020 Jun; 28(6):2553-2562. PubMed ID: 31494735
[TBL] [Abstract][Full Text] [Related]
13. Vinca alkaloids, thalidomide and eribulin-induced peripheral neurotoxicity: From pathogenesis to treatment.
Islam B; Lustberg M; Staff NP; Kolb N; Alberti P; Argyriou AA
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S63-S73. PubMed ID: 31647152
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Marmiroli P
Nat Rev Neurol; 2010 Dec; 6(12):657-66. PubMed ID: 21060341
[TBL] [Abstract][Full Text] [Related]
15. Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN).
Hertz DL; Childs DS; Park SB; Faithfull S; Ke Y; Ali NT; McGlown SM; Chan A; Grech LB; Loprinzi CL; Ruddy KJ; Lustberg M
Cancer Treat Rev; 2021 Sep; 99():102241. PubMed ID: 34174668
[TBL] [Abstract][Full Text] [Related]
16. Incidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study.
Ajewole VB; Cox JE; Swan JT; Chikermane SG; Lamoth B; Iso T; Okolo LO; Ford CL; Schneider AM; Hobaugh EC; Baker KR
Support Care Cancer; 2020 Apr; 28(4):1901-1912. PubMed ID: 31359183
[TBL] [Abstract][Full Text] [Related]
17. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
[TBL] [Abstract][Full Text] [Related]
18. Incidence and disease burden of chemotherapy-induced peripheral neuropathy in a population-based cohort.
Shah A; Hoffman EM; Mauermann ML; Loprinzi CL; Windebank AJ; Klein CJ; Staff NP
J Neurol Neurosurg Psychiatry; 2018 Jun; 89(6):636-641. PubMed ID: 29439162
[TBL] [Abstract][Full Text] [Related]
19. Effects of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Structural Equation Approach With the Theory of Unpleasant Symptoms.
Kim M; Jung MS
Cancer Nurs; 2021 Mar-Apr 01; 44(2):145-153. PubMed ID: 31833921
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Patients With and Without Painful Peripheral Neuropathy After Receiving Neurotoxic Chemotherapy: Traditional Quantitative Sensory Testing vs C-Fiber and Aδ-Fiber Selective Diode Laser Stimulation.
Nemenov MI; Alaverdyan H; Burk C; Roles K; Frey K; Yan Y; Kazinets G; Haroutounian S
J Pain; 2022 May; 23(5):796-809. PubMed ID: 34896646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
